Congenital heart disease
Conditions
Interventions
Dex low dose group:1µg/ml Dex
control group:saline
Dex high dose group:2µg/ml Dex
Sponsors
The Second Affiliated Hospital of Guangxi Medical University
Eligibility
Sex/Gender
All
Age
1 Years to 6 Years
Inclusion criteria
Inclusion criteria: 1. Patients with congenital heart disease (Ventricular septal defect, VSD,and atrioventricular septal defect, ASD). 2. Aged 1 year to 6 years old; 3. ASA I~III; 4. informed consent form from the parent or guardian.
Exclusion criteria
Exclusion criteria: 1. the patients who are not the first-time operation; 2. low birth weight or premature infant; 3. the patients who with serious cyanosis; 4. the patients who with brain paralysis; 5. the patients who with serious failure of respiratory, liver or renal fuction; 6. the patients who with metabolic dysfuction; 7. the patients who has been allergy with dex or high allergic people.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemodynamic index;Hemodynamic index;S-100ß;NSE;CK;CK-MB;H-FABP;H-FABP;Hs-TnT;BUN;Ccr;Cre;NGAL; | — |
Countries
China
Contacts
Public ContactShaopeng Ming
Department of Anesthesology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China
Outcome results
None listed